000			03377nam a2200517 a 4500
001			scn00350024
005			20210413150551.0
006			m|||||||||||||||||
007			cr||n||||||||n
008			161024s2013||||nyu|||||s|||||||||||eng||
010			_a2012024941
020			_a0071741690 (eISBN)
020			_a9780071741699 (e-ISBN)
020			_a9781283656160 (print-ISBN)
020			_a1283656167 (print-ISBN)
020			_a6613968668
020			_a9786613968661
035			_a(OCoLC)793223356
050		4	_aRM301.3.G45 _bP43 2013
060	0	0	_a2012 I-854
060	1	0	_aQV 38.5 _bP534 2013
082	0	4	_a615.1/9 _223
245	0	0	_aPharmacogenomics _h[electronic resource] : _ban introduction and clinical perspective / _cedited by Joseph S. Bertino Jr, C. Lindsay DeVane, Uwe Fuhr, Angela D. M. Kashuba, Joseph D. Ma.
250			_a1st ed.
260			_aNew York, N.Y. : _bMcGraw-Hill Education LLC., _cc2013.
300			_axiii, 274 p. : _bill., figs., tables.
490	1		_aMcGraw-Hill's AccessPharmacy
490	1		_aA Lange medical book
500			_a"A Lange medical book."
504			_aIncludes bibliographical references and indexes.
505	0		_aSection I. General Concepts -- CHAPTER 1. Developing Perspectives on Pharmacogenomics -- CHAPTER 2. Genetic Concepts of Pharmacogenomics: Basic Review of DNA, Genes, Polymorphisms, Haplotypes and Nomenclature -- CHAPTER 3. Analytical Methods to Identify Genetic Variations and Bioinformatics -- CHAPTER 4. Regulatory Considerations in Pharmacogenomics at EMA and US FDA -- CHAPTER 5. Ethical, Legal, and Social Issues Associated with Pharmacogenomics -- CHAPTER 6A. Pharmacogenetics of Cytochrome P450 -- CHAPTER 6B. Phase II Drug-Metabolizing Enzymes -- CHAPTER 7. Drug Transporters -- CHAPTER 8. Nongenetic Influences on Drug Metabolism -- CHAPTER 9. Public Access to Pharmacogenomic Testing and Patient Counseling -- CHAPTER 10. Understanding the Use of Pharmacoeconomic Analysis to Assess the Economic Impact of Pharmacogenomic Testing --Section II. Clinical Application of Pharmacogenomics -- CHAPTER 11. Cardiovascular Pharmacogenomics -- CHAPTER 12. Pharmacogenomics and Pharmacogenetics for Infectious Diseases -- CHAPTER 13. Pharmacogenomics in Oncology -- CHAPTER 14. Psychiatry and Addiction Medicine -- CHAPTER 15. Immunology, Transplantation, and Vaccines -- CHAPTER 16. Pharmacogenomics in Neurology -- CHAPTER 17A. Pharmacogenomics of Gastrointestinal Drugs: Focus on Proton Pump Inhibitors -- CHAPTER 17B. Genomics and the Kidney.
530			_aAlso issued in online and PDF version.
588			_aDescription based on cover image and table of contents, viewed on Oct. 24, 2016.
650		0	_aPharmacogenomics _vTextbooks.
650	1	2	_aPharmacogenetics.
650	2	2	_aPharmaceutical Preparations _xmetabolism.
650	2	2	_aPharmacological Phenomena _xgenetics.
700	1		_aBertino, Joseph S., _eed.
700	1		_aDeVane, Lindsay C., _eed.
700	1		_aKashuba, Angela D. M., _eed.
700	1		_aMa, Joseph D., _eed.
776	0	8	_iOnline version: _tPharmacogenomics, an introduction and clinical perspective. _dNew York, N.Y. : McGraw-Hill Education LLC., _c2013. _z9780071741699. _w(OCoLC)793223356
830		0	_aMcGraw-Hill's AccessPharmacy.
830		0	_aA Lange medical book.
856	4	0	_uhttp://accesspharmacy.mhmedical.com/book.aspx?bookid=511
999			_c1503 _d1503